Hyperleptinemia in women with Cushing's disease is driven by high-amplitude pulsatile, but orderly and eurhythmic, leptin secretion

European Journal of Endocrinology

Volumn 144, Issue 1, 2001, Pages 21-27

  Veldman, R G ^a   Frolich M ^a   Pincus, S M ^a   Veldhuis, J D ^a   Roelfsema, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INSULIN; LEPTIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CUSHING DISEASE; ENTROPY; FEMALE; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPERADRENOCORTICISM; INSULIN BLOOD LEVEL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035151063     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440021     Document Type: Article

References (52)

1. Leptin: Fundamental aspects
2. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
3. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
4. Increased obese mRNA expression in omental fat cells from massively obese humans
5. Effects of gender, body composition, and menopause on plasma concentrations of leptin
6. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure
7. Longitudinal study of leptin concentrations during puberty: Sex differences and relationship to changes in body composition
8. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake
9. Dexamethasone regulates obese expression in isolated rat adipocytes
10. Dexamethasone increases leptin expression in humans in vivo
11. Robust leptin secretory responses to dexamethasone in obese subjects
12. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome
13. Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism
14. Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome: A superior differential diagnostic test
15. Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection
16. Human leptin levels are pulsatile and inversly related to pituitary-adrenal function
17. Sex differences in circulating human leptin pulse amplitude: Clinical implications
18. Deconvolution analysis of hormone data
19. Deconvolution analysis of neuro-endocrine data: Waveform-independent methods and applications
20. Adipose tissue leptin production and plasma leptin kinetics in humans
21. Approximate entropy as a measure of system complexity
22. Randomness and degrees of irregularity
23. Effects of glucocorticoids on energy metabolism and food intake in humans
24. Plasma leptin levels and body fat distribution
25. Circadian rhythm of plasma leptin levels in upper and lower body obese women: Influence of body fat distribution and weight loss
26. Leptin secretion from subcutanuous and visceral adipose tissue in women
27. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease
28. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects
29. Racial differences in plasma leptin concentrations in obese postmenopausal women
30. Growth hormone directly inhibits leptin gene expression in visceral fat tissue in fatty Zucker rats
31. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency
32. Serum leptin is increased in growth hormone-deficient adults: Relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year
33. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
34. The relationship between growth hormone kinetics and sarcopenia in postmenopausal women: The role of fat mass and leptin
35. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease
36. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro
37. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects
38. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
39. Insulin regulation of leptin synthesis and secretion in humans: The model of myotonic dystrophy
40. Leptin secretion in Cushing's syndrome: Preservation of diurnal rhythm and absent response to corticotropin-releasing hormone
41. Determinants of serum leptin levels in Cushing's syndrome
42. Serum leptin levels in women with polycystic ovary syndrome: The role of insulin resistance/hyperinsulinemia
43. Leptin concentrations in polycystic ovary syndrome
44. Circulating leptin concentrations in polycystic ovary syndrome: Relation to anthropometric and metabolic parameters
45. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: Relationship to sleep and body temperature
46. Orderliness of hormone release patterns: A complementary measure to conventional pulsatile and circadian analyses
47. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
48. Increased episodic release and disorderliness of prolactin secretion in both micro- and macro-prolactinomas
49. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease
50. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects
51. Clinical endocrinology of human leptin
52. The effect of adrenal corticosteroids on regional adipocyte size in man